Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Andrew Gwynne on 2016-09-14.

To ask the Secretary of State for Health, whether his Department has had discussions with NICE on the Afinitor form of everolimus.

Nicola Blackwood

Departmental officials are in regular contact with their counterparts at the National Institute for Health and Care Excellence (NICE) about a range of issues, including individual medicines. This includes discussions on everolimus through the established topic selection processes for NICE’s technology appraisal programme and in relation to potential patient access schemes proposed by the manufacturer.

NICE has appraised everolimus for a number of indications and is currently appraising it for others.